If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 151 - 160 of 281
A Prospective, Multicountry Study To Estimate The Incidence Of And Provide A Best Practice Model For Monitoring The Development Of Post-Stroke Spasticity
Objective
Best Practice Model For Monitoring The Development Of Post-Stroke Spasticity
Protocol No
PMR-IPSEN-EPITOME
A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera system in Subjects with Upper Extremity Spasticity
Objective
Iovera in Upper Extremity Spasticity
Protocol No
PMR-PACIRA-IOV-301
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
Objective
Lower Respiratory Tract PIV Infection in Immunocompromised Subjects
Protocol No
PULM-ANSUN-BIOPHARMA-FQ
Categories
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)
Objective
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Protocol No
PULM-GOSSAMER-PROSERA
Categories
A Randomized Controlled Trial of Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Objective
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Protocol No
PULM-RUSH-POSTEXTUBATION
A Phase 3 Open-label Extension (OLE) Study to Evaluate the Long-term Safety and Efficacy of Ralinepag in Subjects With World Health Organization (WHO) Group 1 Pulmonary Arterial Hypertension (PAH)
Objective
Ralinepag in Subjects with PAH via an Open-label Extension
Protocol No
PULM-UNITED-ROR-PH-303
Categories
An Open-label Extension Study of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis
Objective
Extension Study of Inhaled Treprostinil in Subjects With IPF
Protocol No
PULM-UNITED-TETON-OLE
Categories
Measurement of Apathy in Systemic Lupus Erythematosus
Objective
Apathy in Lupus
Protocol No
RHEU-IIT-MCW-APATHY
Categories
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy (IgAN)
Objective
Ravulizumab in Adult Participants with Immunoglobulin A Nephropathy
Protocol No
NEPH-ALEXION-ALXN1210-IGAN-320
Categories
Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain Metastases
Objective
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain
Protocol No
NRG-BN013
Categories
Cancer,
Other Skin,
Bladder,
Colorectal,
Cervix,
Other Gynecologic,
Breast Cancers,
Esophagus,
Prostate,
Larynx,
Other Gastrointestinal,
Esophagus,
Gynecologic Cancers,
Other Respiratory,
Melanoma, Skin,
Prostate and Urologic Cancers,
Pancreas/Liver,
Eye/Orbital Cancers,
Thoracic Cancers,
Lip, Oral Cavity and Pharynx,
Head and Neck Cancers,
Gastrointestinal Cancers,
Endocrine Cancers,
Skin Cancers,
Brain and Spine Cancers